Archive for July 6, 2012

Toxoplasmic lymphadenitis–clinical and serologic profile.

Clin Microbiol Infect. 2003 Jul  V.9 N.7 P.625-31.

Durlach RA, Kaufer F, Carral L, Hirt J.

German Hospital, Buenos Aires, Argentina. rdurlach@hospitaleman.com.ar

Abstract

OBJECTIVE:

To study the serologic profile of several types of test for toxoplasmosis, in order to contribute to the interpretation of antibody kinetics.

METHODS:

The clinical and serologic features of 120 cases of lymphadenopathy with known time of clinical onset were studied during 18 months postinfection. Antibody kinetics was determined by Sabin-Feldman dye test, complement fixation with light antigen, IgM immunofluorescent antibody test, and IgM immunosorbent agglutination assay (IgM-ISAGA). Cell-mediated immunity was evaluated by the toxoplasmin skin test.

RESULTS:

Seventy-five female patients aged 11-54 years (median 27 years) and 45 male patients aged 3-59 years (median 17 years) were studied, 85% of whom were under 30 years of age. Cervical lymph nodes were involved throughout, generally on both sides, with more than one affected ganglion group in 88%. The predominant symptom was asthenia (69%), which persisted in some cases for several months. A negative Sabin-Feldman dye test in a lymphadenopathy with more than three weeks’ evolution excludes a toxoplasma etiology. A positive Sabin-Feldman dye test with negative IgM-ISAGA almost invariably excludes recent infection. The Sabin-Feldman dye test was positive in 94% of patients with titers higher than 1 : 16 000 within the first three months. The IgM-ISAGA yielded 98% of positive results, of which 94% were high titers. Titers >/= 1 :160 inthe IgM immunofluorescent antibody test and complement fixation were found to be highly indicative of recent infection, since 87% and 91%, respectively, were found within the first three months. A negative skin test plus positive serology values indicates recent infection.

CONCLUSION:

Our results indicate that estimation of time of infection on the basis of serologic results is improved by the simultaneous application of several tests, and correlates closely with the presence of clinical lymphadenitis.

FULL TEXT

http://onlinelibrary.wiley.com/doi/10.1046/j.1469-0691.2003.00575.x/full

July 6, 2012 at 2:53 pm

Update on the management of acute pharyngitis in children.

Ital J Pediatr. 2011 Jan 31  N.37  P.10.

Regoli M, Chiappini E, Bonsignori F, Galli L, de Martino M.

Department of Sciences for Woman and Child’s Health, University of Florence, Florence, Italy. marta.regoli@hotmail.it

Abstract

Streptococcal pharyngitis is a very common pathology in paediatric age all over the world. Nevertheless there isn’t a joint agreement on the management of this condition. Some authors recommend to perform a microbiological investigation in suspected bacterial cases in order to treat the confirmed cases with antibiotics so to prevent suppurative complications and acute rheumatic fever. Differently, other authors consider pharyngitis, even streptococcal one, a benign, self-limiting disease. Consequently they wouldn’t routinely perform microbiological tests and, pointing to a judicious use of antibiotics, they would reserve antimicrobial treatment to well-selected cases. It has been calculated that the number of patients needed to treat to prevent one complication after upper respiratory tract infections (including sore throat), was over 4000. Even the use of the Centor score, in order to evaluate the risk of streptococcal infection, is under debate and the interpretation of the test results may vary considerably. Penicillin is considered all over the world as first line treatment, but oral amoxicillin is also accepted and, due to its better palatability, can be a suitable option. Macrolides should be reserved to the rare cases of proved allergy to β-lactams. Cephalosporins can be used in patients allergic to penicillin (with the exception of type I hypersensibility) and have been also proposed to treat the relapses.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042010/pdf/1824-7288-37-10.pdf

 

July 6, 2012 at 2:52 pm

Antimicrobial prophylaxis in adults.

Mayo Clin Proc. 2011 Jul  V.86 N.7  P.686-701.

Enzler MJ, Berbari E, Osmon DR.

Division of Infectious Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. enzler.mark@mayo.edu

Abstract

Antimicrobial prophylaxis is commonly used by clinicians for the prevention of numerous infectious diseases, including herpes simplex infection, rheumatic fever, recurrent cellulitis, meningococcal disease, recurrent uncomplicated urinary tract infections in women, spontaneous bacterial peritonitis in patients with cirrhosis, influenza, infective endocarditis, pertussis, and acute necrotizing pancreatitis, as well as infections associated with open fractures, recent prosthetic joint placement, and bite wounds. Perioperative antimicrobial prophylaxis is recommended for various surgical procedures to prevent surgical site infections. Optimal antimicrobial agents for prophylaxis should be bactericidal, nontoxic, inexpensive, and active against the typical pathogens that can cause surgical site infection postoperatively. To maximize its effectiveness, intravenous perioperative prophylaxis should be administered within 30 to 60 minutes before the surgical incision. Antimicrobial prophylaxis should be of short duration to decrease toxicity and antimicrobial resistance and to reduce cost.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127564/pdf/mayoclinproc_86_7_012.pdf

 

 

July 6, 2012 at 2:50 pm


Calendar

July 2012
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Posts by Month

Posts by Category